Pyrazoles
Concept
Vocabulary Service
Overview
subject area of
-
Lactobacillus reuteriingestion and IKCachannel blockade have similar effects on rat colon motility and myenteric neurones Academic Article
-
A Methanol Intoxication Outbreak From Recreational Ingestion of Fracking Fluid Academic Article
-
A Phase I study of cyclin-dependent kinase inhibitor, AT7519, in patients with advanced cancer: NCIC Clinical Trials Group IND 177 Academic Article
-
A Survey of the Use of Empiric Novel Anticoagulants During Investigation of Stroke Academic Article
-
A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score Academic Article
-
A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer Academic Article
-
A vortex-assisted MSPD method for the extraction of pesticide residues from fish liver and crab hepatopancreas with determination by GC–MS Academic Article
-
Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine—A Multicenter Trial Academic Article
-
Acute management of bleeding in patients on novel oral anticoagulants Academic Article
-
Acute pain after total hip arthroplasty does not predict the development of chronic postsurgical pain 6 months later Academic Article
-
Adherence to apixaban for extended thromboprophylaxis after major abdominal or pelvic surgery for cancer: A prospective cohort study Academic Article
-
Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable b-cell neoplasms: a report of two pilot clinical trials and laboratory investigations Academic Article
-
Advantages and limitations of the new anticoagulants Academic Article
-
An anti-inflammatory drug (BW755C) inhibits airway hyperresponsiveness induced by ozone in dogs Academic Article
-
An assay to measure levels of factor Xa inhibitors in blood and plasma Academic Article
-
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors Academic Article
-
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity Academic Article
-
Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis Academic Article
-
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation Academic Article
-
Anomalous ABO Grouping Due to a New Serum Factor Reactive with a Reagent Coloring Material Academic Article
-
Anticoagulation for Mechanical Heart Valves Academic Article
-
Apixaban for Extended Treatment of Venous Thromboembolism Academic Article
-
Apixaban for Stroke Prevention in Atrial Fibrillation: Why are Event Rates Higher in Clinical Practice than in Randomized Trials?—A Systematic Review Academic Article
-
Apixaban in Acute Coronary Syndromes Academic Article
-
Apixaban in Patients with Atrial Fibrillation Academic Article
-
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer Academic Article
-
Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement Academic Article
-
Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients Academic Article
-
Apixaban versus Enoxaparin in Medically Ill Patients Academic Article
-
Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial Academic Article
-
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial Academic Article
-
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome Academic Article
-
Approach to the new oral anticoagulants in family practice: part 1: comparing the options. Academic Article
-
Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions. Academic Article
-
Appropriate Apixaban Dosing Academic Article
-
Aryl Hydrocarbon Receptor-Dependent Retention of Nuclear HuR Suppresses Cigarette Smoke-Induced Cyclooxygenase-2 Expression Independent of DNA-Binding Academic Article
-
Bacteroides fragilis polysaccharide A is necessary and sufficient for acute activation of intestinal sensory neurons Academic Article
-
Beyond Unfractionated Heparin and Warfarin Academic Article
-
Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin Academic Article
-
Bleeding and antidotes in new oral anticoagulants Academic Article
-
Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience Academic Article
-
Bleeding with direct oral anticoagulants vs warfarin: clinical experience Academic Article
-
Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism Treatment Academic Article
-
Cannabinoids Reveal Separate Controls for Whisking Amplitude and Timing in Rats Academic Article
-
Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study Academic Article
-
Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial Academic Article
-
Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials Academic Article
-
Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials Academic Article
-
Clinical Experience With the New Oral Anticoagulants for Treatment of Venous Thromboembolism Academic Article
-
Clinical implications of reversal agents for direct oral anticoagulants Academic Article
-
Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin Academic Article
-
Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications Academic Article
-
Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure Academic Article
-
Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development Academic Article
-
Comparative effectiveness and safety of direct acting oral anticoagulants in nonvalvular atrial fibrillation for stroke prevention: a systematic review and meta-analysis Academic Article
-
Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study Academic Article
-
Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm? Academic Article
-
Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated partial thromboplastin times using various reagents Academic Article
-
Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2) Academic Article
-
Cost Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients With Advanced ALK-Positive Non–Small-Cell Lung Cancer Academic Article
-
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia Academic Article
-
Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies Academic Article
-
Direct interaction of a small-molecule modulator with G551D-CFTR, a cystic fibrosis-causing mutation associated with severe disease Academic Article
-
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials Academic Article
-
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Academic Article
-
Direct oral anticoagulants: evidence and unresolved issues Academic Article
-
Does Celecoxib Potentiate the Anticoagulant Effect of Warfarin? A Randomized, Double-Blind, Controlled Trial Academic Article
-
Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy Academic Article
-
Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect Academic Article
-
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty Academic Article
-
Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study Academic Article
-
Effect of extended‐duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis Academic Article
-
Effect of nafazatrom on platelet function and release: Relationship to symptomatic episodes in patients with peripheral vascular disease Academic Article
-
Effects of ibrutinib on in vitro platelet aggregation in blood samples from healthy donors and donors with platelet dysfunction Academic Article
-
Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial Academic Article
-
Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial Academic Article
-
Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura (ITP) Academic Article
-
Energy-stress-mediated AMPK activation inhibits ferroptosis Academic Article
-
Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials Academic Article
-
Evolving use of new oral anticoagulants for treatment of venous thromboembolism Academic Article
-
Extended treatment of venous thromboembolism. Academic Article
-
Factor Xa and thrombin as targets for new oral anticoagulants Academic Article
-
Functional characterization of estrogen receptor subtypes, ERα and ERβ, mediating vitellogenin production in the liver of rainbow trout Academic Article
-
Gabapentin Decreases Morphine Consumption and Improves Functional Recovery following Total Knee Arthroplasty Academic Article
-
Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies Academic Article
-
Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy Academic Article
-
High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells Academic Article
-
How I treat target-specific oral anticoagulant–associated bleeding Academic Article
-
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study Academic Article
-
Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties Academic Article
-
Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11C]DPA-713 PET Academic Article
-
Immunological studies with different classes of mutants affected at the adenosine kinase locus in CHO cells Academic Article
-
In AF, apixaban reduced stroke or systemic embolism compared with warfarin, regardless of patient age Academic Article
-
In adults hospitalized with COVID-19, adding baricitinib vs. dexamethasone to remdesivir did not differ for MV-free survival Academic Article
-
In high-risk patients with arthritis and previous upper GI bleeding, celecoxib vs naproxen reduced recurrent bleeding Academic Article
-
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis Academic Article
-
Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation Academic Article
-
Inhibition of arterial thrombosis and platelet function by nafazatrom Academic Article
-
International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants Academic Article
-
Involvement of adenosine kinase in the phosphorylation of formycin B in CHO cells Academic Article
-
Ionizing Radiation Activates AMP-Activated Kinase (AMPK): A Target for Radiosensitization of Human Cancer Cells Academic Article
-
Is there a role for the novel oral anticoagulants in patients with an acute coronary syndrome? A review of the clinical trials Academic Article
-
Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants Academic Article
-
Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation Academic Article
-
Laboratory measurement of the direct oral anticoagulants Academic Article
-
Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia Academic Article
-
Long-Term Treatment with Apixaban in Patients with Atrial Fibrillation: Outcomes during the Open-Label Extension following AVERROES Academic Article
-
Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels Academic Article
-
Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study Academic Article
-
Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting Academic Article
-
Modification of Outcomes With Aspirin or Apixaban in Relation to CHADS
2
and CHA
2
DS
2
-VASc Scores in Patients With Atrial Fibrillation Academic Article
-
Modification of Outcomes With Aspirin or Apixaban in Relation to Female and Male Sex in Patients With Atrial Fibrillation Academic Article
-
Monitoring and reversal of direct oral anticoagulants Academic Article
-
NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank Academic Article
-
New Anticoagulants for Atrial Fibrillation Academic Article
-
New Anticoagulants for Treatment of Venous Thromboembolism Academic Article
-
New Anticoagulants for the Prevention of Thromboembolism Academic Article
-
New Antithrombotic Drugs: Potential for Use in Oncology Academic Article
-
New anticoagulants in atrial fibrillation management Conference Paper
-
New oral anticoagulant agents – general features and outcomes in subsets of patients Academic Article
-
New oral anticoagulants and oculoplastic surgery Academic Article
-
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions Academic Article
-
New oral anticoagulants in elderly patients Academic Article
-
New oral anticoagulants: not quite there yet Academic Article
-
New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses Academic Article
-
Novel Oral Anticoagulants: A Focused Review for Stroke Physicians Academic Article
-
Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism Academic Article
-
Novel oral anticoagulants in gastroenterology practice Academic Article
-
Novel oral anticoagulants in secondary prevention of stroke Academic Article
-
Optimal Prescription of the Lower Dose of Apixaban Academic Article
-
Optimizing the safety of treatment for venous thromboembolism in the era of the direct oral anticoagulants Academic Article
-
Oral Apixaban for the Treatment of Acute Venous Thromboembolism Academic Article
-
Oral Direct Factor Xa Inhibitors Academic Article
-
Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease Academic Article
-
Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial Academic Article
-
Overview of the New Oral Anticoagulants Academic Article
-
Patterns of Ruxolitinib Therapy Failure and Its Management in Myelofibrosis: Perspectives of the Canadian Myeloproliferative Neoplasm Group Academic Article
-
Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale Academic Article
-
Perioperative management of patients who are receiving a novel oral anticoagulant Academic Article
-
Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial Academic Article
-
Periprocedural Management of Oral Anticoagulation Academic Article
-
Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy Academic Article
-
Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients Academic Article
-
Pharmacologic Properties of the New Oral Anticoagulants: A Clinician-oriented Review with a Focus on Perioperative Management Academic Article
-
Phase I trial of lonidamine with whole body hyperthermia in advanced cancer. Academic Article
-
Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study. Academic Article
-
Plasma Apixaban Levels in Patients Treated Off Label With the Lower Dose Academic Article
-
Platelet count or bleeding as the outcome in ITP trials? Academic Article
-
Positioning new treatments in the management of immune thrombocytopenia Academic Article
-
Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation Academic Article
-
Potential of new anticoagulants in patients with cancer Academic Article
-
Practical aspects of new oral anticoagulant use in atrial fibrillation Academic Article
-
Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease. Academic Article
-
Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban Academic Article
-
Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study Academic Article
-
Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study Academic Article
-
Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis Academic Article
-
Randomized phase 2 trial comparing JNJ‐9375, a thrombin‐directed antibody, with apixaban for prevention of venous thrombosis Academic Article
-
Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment Academic Article
-
Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial Academic Article
-
Reducing the risk of recurrent stroke in patients with AF Academic Article
-
Resident Physicians Choices of Anticoagulation for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation Academic Article
-
Response. Academic Article
-
Reversal of Direct Oral Anticoagulants: Current Status and Future Directions Academic Article
-
Review: In renal impairment, apixaban reduces, or does not increase, bleeding compared with other anticoagulants Academic Article
-
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial Academic Article
-
Riociguat for the treatment of pulmonary hypertension Academic Article
-
Riociguat: A Novel Therapeutic Option for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Academic Article
-
Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit) Academic Article
-
Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants Academic Article
-
Risk of hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients with myeloproliferative neoplasms treated with ruxolitinib Academic Article
-
Rivaroxaban for the prevention and treatment of venous thromboembolism Academic Article
-
Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma Academic Article
-
Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available Academic Article
-
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study Academic Article
-
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation Academic Article
-
Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment Academic Article
-
Spindle epithelial tumor with thymus-like elements of the thyroid: a multi-institutional case series and review of the literature Academic Article
-
Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial Academic Article
-
Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease Academic Article
-
Stroke prevention in atrial fibrillation: Closing the gap Academic Article
-
Structure-guided optimization of protein kinase inhibitors reverses aminoglycoside antibiotic resistance Academic Article
-
Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists Academic Article
-
Synergistic effect of purine derivatives on the toxicity of pyrazofurin and 6-azauridine towards cultured mammalian cells Academic Article
-
Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial Academic Article
-
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations Academic Article
-
The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale Academic Article
-
The effects of apixaban on hospitalizations in patients with different types of atrial fibrillation: insights from the AVERROES trial Academic Article
-
The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1receptor antagonism ? or inverse agonism ? as potential obesity treatment and other therapeutic use Academic Article
-
The gut microbiome restores intrinsic and extrinsic nerve function in germ‐free mice accompanied by changes in calbindin Academic Article
-
The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis Academic Article
-
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study Academic Article
-
The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis Academic Article
-
The top 4 advances in antithrombotic care in the last year Academic Article
-
Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline Academic Article
-
Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Academic Article
-
Thrombopoietin-Receptor Agonists for Primary Immune Thrombocytopenia Academic Article
-
Transition from apixaban to warfarin—addressing excess stroke, systemic embolism, and major bleeding Academic Article
-
Trends in Prescribing Oral Anticoagulants in Canada, 2008–2014 Academic Article
-
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma Academic Article
-
Use of a competitive inhibitor in a kinetic enzymatic method for measuring ethanol in serum. Academic Article
-
Venous thromboembolism management: where do novel anticoagulants fit? Academic Article
-
Well-managed warfarin is superior to NOACs Response Academic Article